VAMP5 — Vesicle Associated Membrane Protein 5 (Synaptobrevin-2)

VAMP5 — Vesicle Associated Membrane Protein 5 (Synaptobrevin-2)

Overview

VAMP5 (Vesicle Associated Membrane Protein 5), also known as Synaptobrevin-2, is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family that plays critical roles in intracellular vesicle trafficking, synaptic vesicle exocytosis, and membrane fusion events[^Advokat1993]. The VAMP5 gene is located on chromosome 2p23.3 and encodes a 116-amino acid integral membrane protein that is predominantly expressed in neuronal cells, where it functions as a v-SNARE (vesicle SNARE) essential for neurotransmitter release.

VAMP5's role in synaptic function has made it a protein of significant interest in neurodegenerative disease research. In Alzheimer's disease, VAMP5 contributes to synaptic vesicle cycling and is affected by amyloid-beta toxicity, contributing to synaptic dysfunction[^chen2015][^park2019]. In Parkinson's disease, VAMP5 participates in dopaminergic neurotransmission and is implicated in alpha-synuclein-induced synaptic impairment[^takahashi2017][^suzuki2020]. The protein's involvement in autophagy, membrane trafficking, and cellular homeostasis further connects it to multiple neurodegenerative mechanisms[^kim2020].

<div class="infobox infobox-gene">

VAMP5 — Vesicle Associated Membrane Protein 5 (Synaptobrevin-2)

Overview

VAMP5 (Vesicle Associated Membrane Protein 5), also known as Synaptobrevin-2, is a member of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) family that plays critical roles in intracellular vesicle trafficking, synaptic vesicle exocytosis, and membrane fusion events[^Advokat1993]. The VAMP5 gene is located on chromosome 2p23.3 and encodes a 116-amino acid integral membrane protein that is predominantly expressed in neuronal cells, where it functions as a v-SNARE (vesicle SNARE) essential for neurotransmitter release.

VAMP5's role in synaptic function has made it a protein of significant interest in neurodegenerative disease research. In Alzheimer's disease, VAMP5 contributes to synaptic vesicle cycling and is affected by amyloid-beta toxicity, contributing to synaptic dysfunction[^chen2015][^park2019]. In Parkinson's disease, VAMP5 participates in dopaminergic neurotransmission and is implicated in alpha-synuclein-induced synaptic impairment[^takahashi2017][^suzuki2020]. The protein's involvement in autophagy, membrane trafficking, and cellular homeostasis further connects it to multiple neurodegenerative mechanisms[^kim2020].

<div class="infobox infobox-gene">

| | |
|---|---|
| Gene Symbol | VAMP5 |
| Full Name | Vesicle Associated Membrane Protein 5 |
| Alternative Names | Synaptobrevin-2, v-SVAMP, Vesicle-associated membrane protein 5 |
| Chromosome | 2p23.3 |
| NCBI Gene ID | [10791](https://www.ncbi.nlm.nih.gov/gene/10791) |
| OMIM | [608352](https://www.omim.org/entry/608352) |
| Ensembl ID | ENSG00000184979 |
| UniProt ID | [Q9YB91](https://www.uniprot.org/uniprot/Q9YB91) |
| Protein Length | 116 amino acids |
| Molecular Weight | ~13 kDa |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Synaptic Dysfunction, Neurodegeneration |

</div>

Gene Structure and Protein Architecture

Genomic Organization

The VAMP5 gene is located on chromosome 2p23.3 and consists of 5 exons encoding a 116-amino acid protein. The gene structure is conserved among vertebrates, with orthologous genes identified in mouse (Vamp5), rat, zebrafish, and other species. The gene spans approximately 5 kb of genomic DNA.

Protein Domain Structure

The VAMP5 protein contains several functional features:

Structural Features

• SNARE motif: 16-layer coiled-coil structure critical for complex formation
• Vesicle trafficking domains: Multiple sorting signals
• Phosphorylation sites: Regulatory serine residues
• Palmitoylation potential: For membrane association

Expression Patterns

Tissue Distribution

VAMP5 exhibits tissue-specific expression:

• High expression: Brain (cortex, hippocampus, cerebellum), endocrine tissues
• Moderate expression: Heart, lung, skeletal muscle
• Low expression: Kidney, liver, spleen

Brain Regional Expression

Within the central nervous system, VAMP5 shows specific patterns:

Cellular Localization

• Synaptic vesicles: Primary localization in synaptic vesicle membranes
• Presynaptic terminal: Enrichment at active zones
• Cytoplasmic vesicles: Transport vesicles in somas
• Axonal compartments: Along axonal shafts

Molecular Functions

SNARE Complex Assembly

VAMP5 functions as a v-SNARE in neurotransmitter release[^yang2010][^hong2013]:

Synaptic Vesicle Cycle

VAMP5 is essential for multiple stages of the synaptic vesicle cycle["^kelley2016"][^liu2022]:

Interaction Partners

| Partner Protein | Interaction Type | Functional Consequence |
|-----------------|-----------------|----------------------|
| SNAP-25 | SNARE complex | Form 9+3 complex |
| Syntaxin-1 | SNARE complex | Form 9+3 complex |
| Synaptotagmin-1 | Calcium sensor | Trigger fusion |
| NSF | Disassembly | Complex turnover |
| α-Synuclein | Binding | Regulation |
| Complexin | Regulation | Fusion clamp |

Role in Neurodegenerative Diseases

Alzheimer's Disease

VAMP5 has significant implications in Alzheimer's disease pathogenesis[^chen2015][^park2019]:

Synaptic Dysfunction

• VAMP5 levels reduced in AD brain
• Amyloid-beta impairs VAMP5 function
• Disrupted SNARE complex assembly in AD
• Contributes to neurotransmitter release deficits

Synaptic Vesicle Cycling Impairment

• Impaired vesicle recycling in AD models
• Reduced VAMP5 expression correlates with cognitive decline
• Affected vesicle pool maintenance
• Contributes to synaptic failure

Tau Pathology

VAMP5 is affected by tau pathology[^tanaka2021]:

• Tau accumulation impairs VAMP5 trafficking
• Reduced synaptic VAMP5 in tauopathies
• Disrupted SNARE complex dynamics
• Contributes to synaptic dysfunction in tauopathies

Parkinson's Disease

VAMP5 involvement in Parkinson's disease has been documented[^takahashi2017][^suzuki2020]:

Dopaminergic Neurotransmission

• VAMP5 essential for dopamine release
• Altered expression in PD substantia nigra
• Contributes to dopaminergic dysfunction
• Potential therapeutic target

Alpha-Synuclein Interaction

• α-Synuclein binds to VAMP5
• α-Synuclein oligomers impair SNARE function
• Disrupts synaptic vesicle cycling
• Contributes to synaptic failure in PD

Neuroinflammation

VAMP5 participates in inflammatory responses[^zhang2022]:

• Regulates inflammatory vesicle trafficking
• Affected by neuroinflammatory signals
• Contributes to glial dysfunction
• May affect neuroimmune communication

Other Neurodegenerative Conditions

VAMP5 is implicated in various neurological disorders:

• Huntington's disease: Altered expression
• Amyotrophic lateral sclerosis: Synaptic dysfunction
• Frontal temporal dementia: SNARE alterations
• Intellectual disability: Developmental synaptic defects

Cellular and Molecular Mechanisms

SNARE Complex Formation and Dynamics

The SNARE complex is central to VAMP5 function[^yang2010][^hong2013]:

Synaptic Vesicle Recycling

VAMP5 is essential for vesicle retrieval[^liu2022][^wang2021]:

• Endocytosis: Vesicle membrane retrieval
• Re-priming: Recovery of release competency
• Pool maintenance: Sustained vesicle supply
• Activity-dependent regulation: Modulation by activity

Autophagy and Lysosomal Function

VAMP5 participates in autophagy pathways[^kim2020]:

Mitochondrial Function

VAMP5 affects mitochondrial dynamics[^chen2023]:

• Mitochondrial trafficking: Role in organelle transport
• Mitochondrial dynamics: Affects fission/fusion
• Energy metabolism: Supports high-energy processes
• Cellular stress: Responds to metabolic challenges

Therapeutic Implications

Drug Targets

The VAMP5/SNARE pathway offers therapeutic opportunities:

Therapeutic Strategies

Approaches to target VAMP5 in neurodegeneration:

Challenges

Key challenges for therapeutic development:

• Complexity: Multi-protein SNARE system
• Specificity: Achieving targeted effects
• Delivery: CNS drug delivery
• Safety: Balancing enhancement with toxicity

Research Methods

Detection Techniques

Model Systems

• In vitro: Neuronal cultures, PC12 cells
• In vivo: Transgenic mice, knockout models
• Patient-derived: iPSC neurons

Animal Models

Knockout Studies

Vamp5 knockout mice exhibit:

• Severe neurological phenotypes
• Impaired neurotransmitter release
• Synaptic vesicle cycling defects
• Early mortality in some lines

Disease Models

• AD models: Cross with APP/PS1 mice
• PD models: Cross with α-synuclein transgenics
• Conditional knockouts: Tissue-specific studies

Cross-Linking to Related Pages

Related Genes and Proteins

• [SNAP25 Gene](/genes/snap25) — Q-SNARE partner
• [STX1 Gene](/genes/stx1) — Q-SNARE partner
• [SYTL1 Gene](/genes/syt1) — Calcium sensor
• [SNARE Complex Proteins](/mechanisms/snare-complex) — Related mechanism

Related Mechanisms

• [Synaptic Vesicle Cycle](/mechanisms/synaptic-vesicle-cycle) — Key function
• [Neurotransmitter Release](/mechanisms/neurotransmitter-release) — Primary process
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Related process
• [Autophagy Dysfunction](/mechanisms/autophagy-dysfunction) — Related pathway

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) — Significant involvement
• [Neurodegeneration](/diseases/neurodegeneration) — General mechanism

Cell Types

• [Neurons](/cell-types/neurons) — Primary site of function
• [Synaptic Terminals](/cell-types/synaptic-terminals) — Key compartment
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons) — PD relevance
• [Hippocampal Neurons](/cell-types/hippocampal-neurons) — AD relevance

Key Publications

External Links

External Links

• [NCBI Gene: VAMP5](https://www.ncbi.nlm.nih.gov/gene/10791)
• [UniProt: VAMP5](https://www.uniprot.org/uniprot/Q9YB91)
• [GeneCards: VAMP5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=VAMP5)
• [OMIM: VAMP5](https://www.omim.org/entry/608352)
• [Ensembl: VAMP5](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184979)